To continue the investigation, we measured the plasma concentrations of GP73 in 14 non-obese healthy controls and 14 NAFLD individuals without obesity diagnosed with MRI (Supplementary Table 1). This evidence concerns the gene GOLM1 and metabolic dysfunction-associated steatotic liver disease.